Asset Details
Do you wish to reserve the book?
The Origins of Antimalarial-Drug Resistance
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Origins of Antimalarial-Drug Resistance
Do you wish to request the book?
The Origins of Antimalarial-Drug Resistance
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Origins of Antimalarial-Drug Resistance
2014
Overview
There is a tendency to view the development of antimalarial-drug resistance as an inevitable outcome of the drugs' widespread use. Yet resistance has been accelerated by the way the drugs are used and by the social and economic conditions in which they are used.
Drugs have been used to treat and prevent malaria for centuries. Bark from the cinchona tree, which contained an array of alkaloids with antimalarial properties, appeared in Western therapeutics in the 17th century. One of the alkaloids, quinine, was isolated in 1820 and became the drug of choice for treating malaria until World War II, when supplies of the drug for much of the world were cut off by the Japanese occupation of cinchona-growing regions in Southeast Asia. Efforts to create alternatives to quinine led to the search for synthetic antimalarial drugs. Chloroquine, first developed in the 1930s, became the . . .
Publisher
Massachusetts Medical Society
